深圳微芯生物科技股份有限公司关于 “微芯转债” 预计满足转股价格修正条件的提示性公告

Group 1 - The company issued convertible bonds totaling RMB 500 million, with a maturity of six years from July 5, 2022, to July 4, 2028 [2] - The initial conversion price for the bonds was set at RMB 25.36 per share, effective from January 11, 2023 [2] - The conversion price was adjusted to RMB 25.26 per share starting June 4, 2024, due to a reduction in the company's total share capital [3] Group 2 - The company has a provision for downward adjustment of the conversion price if the stock price falls below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [4] - If the conditions for price adjustment are met, the board will propose a new conversion price to be approved by shareholders, requiring a two-thirds majority [4] - The company will announce any adjustments to the conversion price through the Shanghai Stock Exchange and will resume conversion applications at the adjusted price [5][6] Group 3 - From May 15 to May 28, 2025, the company's stock price has been below RMB 21.47, which is 85% of the current conversion price, indicating a potential trigger for price adjustment [6] - If the stock price continues to meet the adjustment criteria for 20 consecutive trading days, the company will convene a board meeting to decide on the adjustment [6]